Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia: A Multicenter Randomized Controlled Clinical Trial

NCT02913118 is registered in ClinicalTrials.gov with Qingfeng Pharmaceutical Group as lead sponsor.

NCT NCT02913118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02913118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia: A Multicenter Randomized Controlled Clinical Trial
Lead sponsor
Qingfeng Pharmaceutical Group
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2016
Completion date
June 30, 2019
Enrollment
462 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia